The p210 transcript was previously found in 30.9%, p190 in 27.8%, both transcripts in 2.4%, and e6a2 in 1.6% of patients with AML with BCR::ABL1 [23]. This evidence concerns the gene ABL1 and acute myeloid leukemia.